神采的加薪小武士2017-01-11 21:57
$KalVista Pharmaceuticals, Inc. Common Stock(KALV)$ kalvista是用于治疗遗传性血管水肿发展血浆激肽释放酶抑制剂(HAE)和 糖尿病黄斑水肿(DME);指征,过度的血浆激肽释放酶活性有关,但 那里仍有大量未满足的临床需求。kalvista已经建造了一个扩大的临床和临床前的产品管道先进 针对多种给...查看全文
神采的加薪小武士2017-01-11 21:57
$KalVista Pharmaceuticals, Inc. Common Stock(KALV)$ kalvista是一家制药公司,致力于发现,开发和商业化的小分子蛋白酶抑制剂 作为重大疾病的新疗法 未满足的需求。kalvista制药任命爱德华P. Feener博士为首席科学官,查看全文
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014450 Size: 6 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014451 Size: 6 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014000 Size: 17 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014001 Size: 17 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014007 Size: 17 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014004 Size: 17 KB 网页链接
$KalVista(KALV)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-24-046481 Act: 34 Size: 176 KB 网页链接
$KalVista(KALV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-011318 Size: 9 KB 网页链接
$KalVista(KALV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011319 Size: 5 KB 网页链接
$KalVista(KALV)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-083385 Act: 34 Size: 67 KB 网页链接